|
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H6 - code c19: review of device manufacturing record history confirmed device met pre-release specifications.H6 ¿ code b20: device remains implanted, and no images were provided; therefore, direct product analysis was not possible.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
On (b)(6) 2025, this 61-year-old male patient underwent endovascular treatment for a common iliac artery aneurysm.This was a reintervention of a prior endovascular procedure.It is unknown if the prior endovascular procedure was a gore® endovascular device.The sites were accessed percutaneously on the right.The patient was treated with a gore® excluder® iliac branch endoprosthesis iliac branch component device in the right internal iliac artery, a gore® excluder® aaa endoprosthesis contralateral leg device in the right internal iliac artery, and a gore® viabahn® vbx balloon expandable endoprosthesis (vbx device) in the right internal iliac artery.The gore® devices were successfully navigated to the intended location and successfully deployed.Device catheters were successfully removed after successful access, delivery and deployment of the device.There were no access-related complications.The patient was discharged home on (b)(6) 2025.On (b)(6), 2025, the patient had thrombosis of the right common iliac artery and right external iliac artery.On (b)(6)2025, the patient underwent thrombectomy with implant of a gore® viabahn® vbx balloon expandable endoprosthesis device.The outcome for this adverse event was noted to be recovered/resolved without sequelae on (b)(6) 2025.
|